Neonatal vaccination with Mycobacterium bovis BCG: Potential effects as a priming agent shown in a heterologous prime-boost immunization protocol

Vaccine

Volumn 27, Issue 30, 2009, Pages 4038-4046

  Rahman, Muhammad Jubayer ^a   Fernández, Carmen ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

BCG vaccine; Heparin binding hemagglutinin; Neonates

Indexed keywords

BCG VACCINE; HEPARIN BINDING HEMAGGLUTININ ADHESION; HEPARIN BINDING PROTEIN; MYCOBACTERIUM ANTIGEN; UNCLASSIFIED DRUG;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNE SYSTEM; IMMUNIZATION; INFECTION PREVENTION; MALE; MOUSE; MYCOBACTERIUM BOVIS; NEWBORN; NEWBORN PERIOD; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; VACCINATION;

ADMINISTRATION, INTRANASAL; ANIMALS; BACTERIAL PROTEINS; BCG VACCINE; COLONY COUNT, MICROBIAL; FEMALE; IMMUNIZATION, SECONDARY; INJECTIONS, SUBCUTANEOUS; LUNG; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; SPLEEN; TUBERCULOSIS;

EID: 67349106109     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.027     Document Type: Article

References (41)

1. Haile M., and Källenius G. Recent developments in tuberculosis vaccines. Curr Opin Infect Dis 18 3 (2005) 211-215
2. Dye C., Scheele S., Dolin P., Pathania V., and Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282 7 (1999) 677-686
3. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271 9 (1994) 698-702
4. Colditz G.A., Berkey C.S., Mosteller F., Brewer T.F., Wilson M.E., Burdick E., et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 96 1 Pt 1 (1995) 29-35
5. Udani P.M. BCG vaccination in India and tuberculosis in children: newer facets. Indian J Pediatr 61 5 (1994) 451-462
6. Trunz B.B., Fine P., and Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367 9517 (2006) 1173-1180
7. Garcia A.M., Fadel S.A., Cao S., and Sarzotti M. T cell immunity in neonates. Immunol Res 22 2-3 (2000) 177-190
8. Siegrist C.A. Neonatal and early life vaccinology. Vaccine 19 25-26 (2001) 3331-3346
9. Adkins B. T-cell function in newborn mice and humans. Immunol Today 20 7 (1999) 330-335
10. Kamath A.T., Rochat A.F., Valenti M.P., Agger E.M., Lingnau K., Andersen P., et al. Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant. PLoS ONE 3 11 (2008) e3683
11. Vekemans J., Amedei A., Ota M.O., D'Elios M.M., Goetghebuer T., Ismaili J., et al. Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol 31 5 (2001) 1531-1535
12. Rodrigues L.C., Pereira S.M., Cunha S.S., Genser B., Ichihara M.Y., de Brito S.C., et al. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 366 9493 (2005) 1290-1295
13. Brewer T.F., and Colditz G.A. Relationship between bacille Calmette-Guérin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. Clin Infect Dis 20 1 (1995) 126-135
14. Fine P.E.M., Carneiro I.A.M., Milstein J.B., and Clements C.J. Issues relating to the use of BCG in immunization programmes (1999), World Health Organization, Geneva
15. Santosuosso M., McCormick S., Zhang X., Zganiacz A., and Xing Z. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect Immun 74 8 (2006) 4634-4643
16. Dietrich J., Andersen C., Rappuoli R., Doherty T.M., Jensen C.G., and Andersen P. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. J Immunol 177 9 (2006) 6353-6360
17. Dietrich J., Billeskov R., Doherty T.M., and Andersen P. Synergistic effect of bacillus calmette guerin and a tuberculosis subunit vaccine in cationic liposomes: increased immunogenicity and protection. J Immunol 178 6 (2007) 3721-3730
18. Parra M., Pickett T., Delogu G., Dheenadhayalan V., Debrie A.S., Locht C., et al. The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis. Infect Immun 72 12 (2004) 6799-6805
19. Temmerman S., Pethe K., Parra M., Alonso S., Rouanet C., Pickett T., et al. Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin. Nat Med 10 9 (2004) 935-941
20. Menozzi F.D., Rouse J.H., Alavi M., Laude-Sharp M., Muller J., Bischoff R., et al. Identification of a heparin-binding hemagglutinin present in mycobacteria. J Exp Med 184 3 (1996) 993-1001
21. Pethe K., Alonso S., Biet F., Delogu G., Brennan M.J., Locht C., et al. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 412 6843 (2001) 190-194
22. Masungi C., Temmerman S., Van Vooren J.P., Drowart A., Pethe K., Menozzi F.D., et al. Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J Infect Dis 185 4 (2002) 513-520
23. Wang J., Thorson L., Stokes R.W., Santosuosso M., Huygen K., Zganiacz A., et al. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J Immunol 173 10 (2004) 6357-6365
24. Giri P.K., Sable S.B., Verma I., and Khuller G.K. Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis. FEMS Immunol Med Microbiol 45 1 (2005) 87-93
25. Freytag L.C., and Clements J.D. Mucosal adjuvants. Vaccine 23 15 (2005) 1804-1813
26. Holmgren J., Adamsson J., Anjuère F., Clemens J., Czerkinsky C., Eriksson K., et al. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol Lett. 97 2 (2005) 181-188
27. Tritto E., Muzzi A., Pesce I., Monaci E., Nuti S., Galli G., et al. The acquired immune response to the mucosal adjuvant LTK63 imprints the mouse lung with a protective signature. J Immunol. 179 8 (2007) 5346-5357
28. Delogu G., and Brennan M.J. Functional domains present in the mycobacterial hemagglutinin, HBHA. J Bacteriol 181 24 (1999) 7464-7469
29. Rothfuchs A.G., Gigliotti D., Palmblad K., Andersson U., Wigzell H., and Rottenberg M.E. IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J Immunol 167 11 (2001) 6453-6461
30. Goonetilleke N.P., McShane H., Hannan C.M., Anderson R.J., Brookes R.H., and Hill A.V. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J Immunol 171 3 (2003) 1602-1609
31. Ota M.O., Vekemans J., Schlegel-Haueter S.E., Fielding K., Sanneh M., Kidd M., et al. Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol 168 2 (2002) 919-925
32. Delogu G., Sanguinetti M., Posteraro B., Rocca S., Zanetti S., and Fadda G. The hbhA gene of Mycobacterium tuberculosis is specifically upregulated in the lungs but not in the spleens of aerogenically infected mice. Infect Immun 74 5 (2006) 3006-3011
33. Kohama H., Umemura M., Okamoto Y., Yahagi A., Goga H., Harakuni T., et al. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice. Vaccine 26 7 (2008) 924-932
34. Romano M., D'Souza S., Adnet P.Y., Laali R., Jurion F., Palfliet K., et al. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Vaccine 24 16 (2006) 3353-3364
35. Hesseling A.C., Rabie H., Marais B.J., Manders M., Lips M., Schaaf H.S., et al. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 42 4 (2006) 548-558
36. Lotte A., ten Dam H.G., and Henderson R. Second IUATLD study on complications induced by intradermal BCG vaccination. Bull Int Union Tuberc Lung Dis 63 2 (1988) 47-59
37. Forbes E.K., Sander C., Ronan E.O., McShane H., Hill A.V., Beverley P.C., et al. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol 181 7 (2008) 4955-4964
38. Mazzantini R.P., Miyaji E.N., Dias W.O., Sakauchi D., Nascimento A.L., Raw I., et al. Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C. Vaccine 22 5-6 (2004) 740-746
39. Matsumoto S., Yukitake H., Kanbara H., and Yamada T. Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies. J Exp Med 188 5 (1998) 845-854
40. Chambers M.A., Marshall B.G., Wangoo A., Bune A., Cook H.T., Shaw R.J., et al. Differential responses to challenge with live and dead Mycobacterium bovis Bacillus Calmette-Guérin. J Immunol 158 4 (1997) 1742-1748
41. Gonçalves E.D., Bonato V.L., da Fonseca D.M., Soares E.G., Brandão I.T., Soares A.P., et al. Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming. Genet Vaccines Ther 5 (2007) 7